Let's Talk About Partial Agonists and Antagonist/Partial Agonists


Is that drug a partial agonist … or a partial agonist?

In this Mental Health Minute video, John J. Miller, MD, editor in chief of Psychiatric TimesTM, discusses the importance of specifically defining a drug’s mechanism as a partial agonist or antagonist/partial agonist for improving clinical outcomes.

To learn more about partial agonists and antagonist/partial agonists, see Miller’s article from the December 2021 issue of Psychiatric TimesTM, “Is That Drug a Partial Agonist or a Partial Agonist?

Dr Miller is medical director, Brain Health, Exeter, New Hampshire; Editor in Chief, Psychiatric TimesTM; staff psychiatrist, Seacoast Mental Health Center, Exeter; consulting psychiatrist, Exeter Hospital, Exeter; and consulting psychiatrist, Insight Meditation Society, Barre, Massachusetts.

Related Videos
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
A new treatment in development is poised to be a game-changer for patients with postpartum depression.
An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.
© 2024 MJH Life Sciences

All rights reserved.